Elevated levels of CD8+ T cells have been found to be correlated with unfavorable outcomes in various types of cancer, including prostate cancer, clear cell renal cell carcinoma (RCC), Hodgkin lymphoma, and follicular lymphoma [25,26,27,28,29]. Here, CD8A is linked to prostate carcinoma.